San Luis Wealth Advisors LLC Buys New Stake in Kenvue Inc. $KVUE

San Luis Wealth Advisors LLC bought a new stake in shares of Kenvue Inc. (NYSE:KVUE) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 52,880 shares of the company’s stock, valued at approximately $1,011,000.

A number of other large investors have also recently bought and sold shares of the stock. Arrowstreet Capital Limited Partnership acquired a new position in shares of Kenvue in the second quarter worth $6,528,000. Jump Financial LLC boosted its stake in shares of Kenvue by 210.6% during the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after acquiring an additional 37,170 shares during the last quarter. AXA S.A. increased its position in Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after purchasing an additional 8,524 shares in the last quarter. NewEdge Advisors LLC increased its position in Kenvue by 219.1% during the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock worth $2,040,000 after purchasing an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its stake in Kenvue by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after purchasing an additional 10,885 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on KVUE. Citigroup reduced their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Wall Street Zen downgraded shares of Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Barclays boosted their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. UBS Group reduced their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday. Finally, Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $19.27.

Kenvue Stock Performance

Kenvue stock opened at $18.97 on Thursday. The stock has a fifty day moving average price of $18.88 and a 200 day moving average price of $18.12. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $21.95. The firm has a market capitalization of $36.44 billion, a P/E ratio of 21.80, a PEG ratio of 1.36 and a beta of 0.47. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The business had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.29 earnings per share. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 4.4%. The ex-dividend date is Wednesday, August 12th. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is currently 95.40%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.